Top 50 Medical Startup Investors in Austria (November 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
XISTA Science Ventures
VC Fund
|
8 | Austria, Germany, France | Seed, Pre-Seed, Series A | Biotechnology, Medical, Software | $552k–$20M |
|
SOSV
VC Fund
|
8 | United States, China, Canada | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | $25k–$5M |
|
Speedinvest
VC Fund
|
6 | United Kingdom, Germany, Austria | Seed, Series A, Pre-Seed | Software, FinTech, Artificial Intelligence | $411k–$32M |
|
xista science ventures
VC Fund
|
5 | Austria, Slovenia | Seed, Pre-Seed, Series A | Biotechnology, Medical, Software | $552k–$20M |
|
APEX Ventures
VC Fund
|
4 | Germany, United Kingdom, Austria | Seed, Series A, Pre-Seed | Artificial Intelligence, Software, Health Care | $552k–$22M |
|
Arax Capital Partners
VC Fund
|
3 | Austria, United States | Venture - Series Unknown, Seed, Series A | Biotechnology, Medical, Health Care | $325k–$11M |
|
SquareOne Venture Capital
VC Fund
|
3 | Germany, United States, Poland | Seed, Series A, Series B | Software, Artificial Intelligence, SaaS | $1M–$30M |
|
tecnet equity
VC Fund
|
3 | Austria | Seed, Series A, Venture - Series Unknown | Software, Biotechnology, Artificial Intelligence | $208k–$20M |
|
austria Wirtschaftsservice (aws)
VC Fund
|
3 | Austria, Belgium, Philippines | Seed, Grant, Pre-Seed | Software, Artificial Intelligence, Information Technology | $61k–$2.7M |
|
Austria Wirtschaftsservice (AWS)
VC Fund
|
3 | Austria, Philippines | Seed, Pre-Seed, Grant | Medical, Machine Learning, Artificial Intelligence | $510k–$2.3M |
|
The Austrian Research Promotion Agency (FFG)
VC Fund
|
3 | Austria, United States, Belgium | Grant, Seed, Pre-Seed | Software, Artificial Intelligence, Medical | $67k–$2.8M |
|
Cherry Ventures
VC Fund
|
3 | Germany, United Kingdom, United States | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Information Technology | $1.1M–$44M |
|
MassMutual Ventures
VC Fund
|
3 | United States, Singapore, India | Series A, Series B, Seed | Financial Services, Software, Information Technology | $2.7M–$50M |
|
SkyGene
VC Fund
|
2 | Austria | Venture - Series Unknown | Medical, Health Care, Biotechnology | |
|
Rene Schneider
Angel
|
2 | Austria | Seed, Series A | Medical, Analytics, Health Diagnostics | |
|
VP Venture Partners
VC Fund
|
2 | Austria, Germany, Switzerland | Seed, Pre-Seed, Series B | Medical, Health Care, Biotechnology | $3M–$16M |
|
West Asia Investment Partners S.a.r.l.
VC Fund
|
2 | Austria | Seed, Series A | Medical, Analytics, Health Diagnostics | |
|
aws Gründungsfonds
VC Fund
|
2 | Austria, Germany, United States | Seed, Series A, Venture - Series Unknown | Software, SaaS, Information Technology | $1.1M–$11M |
|
Kinled Holding
VC Fund
|
2 | United Kingdom, United States, Switzerland | Seed, Series A, Venture - Series Unknown | Health Care, Biotechnology, Software | $594k–$40M |
|
FREE VALLEY HOLDINGS LIMITED
VC Fund
|
2 | Austria | Seed, Series A | Medical, Analytics, Health Diagnostics | |
|
Daniel Schulte-Hillen
Angel
|
2 | Germany, United Kingdom, Austria | Seed, Pre-Seed, Series A | Blockchain, Sports, Battery | $1.1M–$7.5M |
|
Johann Hansmann
Angel
|
2 | Austria, United Kingdom, Germany | Seed, Angel, Pre-Seed | Software, Health Care, Fitness | $300k–$3.4M |
|
Sven Jungmann
Angel
|
2 | Austria | Seed, Pre-Seed | Medical, Medical Device | |
|
bmp Ventures
VC Fund
|
2 | Germany, United States, Austria | Seed, Venture - Series Unknown, Series A | Software, Information Technology, Manufacturing | $162k–$12M |
|
Ligand Pharmaceuticals
VC Fund
|
2 | United States, Austria, Denmark | Post-IPO Debt, Corporate Round, Post-IPO Equity | Biotechnology, Medical, Health Care | $3M–$90M |
|
eQventure
VC Fund
|
2 | Austria, Germany, Switzerland | Seed, Series A, Series B | Software, Information Technology, Automotive | $540k–$13M |
|
HV Capital
VC Fund
|
2 | Germany, United States, United Kingdom | Series A, Seed, Series B | E-Commerce, Software, Internet | $1.5M–$75M |
|
MMC Ventures
VC Fund
|
2 | United Kingdom, United States, France | Seed, Series A, Series B | Software, Artificial Intelligence, Machine Learning | $1.6M–$54M |
|
Peak Pride
VC Fund
|
2 | Austria, Germany | Seed, Series A, Pre-Seed | Health Care, Medical, Health Diagnostics | $165k–$6.5M |
|
Medicus Ltd
VC Fund
|
2 | Austria | Angel, Series A | Medical, Analytics, Health Diagnostics | |
|
MIG Capital
VC Fund
|
2 | Germany, France, Austria | Series A, Series B, Venture - Series Unknown | Biotechnology, Health Care, Software | $1.7M–$60M |
|
LANA Ventures
VC Fund
|
2 | Austria, Germany | Seed, Pre-Seed | Health Care, Medical, Software | $2.8M–$7.4M |
|
GLS Ventures
VC Fund
|
1 | Austria | Series B | Medical, Health Care, Biotechnology | |
|
TBA Network
VC Fund
|
1 | Austria, Italy | Seed | Apps, Medical, mHealth | |
|
redalpine
VC Fund
|
1 | Germany, Switzerland, United Kingdom | Seed, Series A, Series B | Biotechnology, Health Care, Software | |
|
Techno Venture Management
VC Fund
|
1 | United States, Germany, United Kingdom | Series B, Series A | Biotechnology, Health Care, Pharmaceutical | $4.7M–$44M |
|
Lead Ventures
VC Fund
|
1 | Hungary, United Kingdom, Croatia | Series A, Seed, Series B | Software, SaaS, Artificial Intelligence | |
|
Tensor Ventures
VC Fund
|
1 | Czech Republic, United States, United Kingdom | Pre-Seed, Seed | Artificial Intelligence, Information Technology, Machine Learning | |
|
IT-Farm
VC Fund
|
1 | United States, Japan, Germany | Seed, Series A | Software, Health Care, Medical | $1.8M–$20M |
|
HBM Partners
VC Fund
|
1 | United States, Germany, Switzerland | Series B, Series C, Convertible Note | Biotechnology, Health Care, Medical | $600k–$125M |
|
i&i Biotech Fund
VC Fund
|
1 | Czech Republic, India, Spain | Seed, Series A | Biotechnology, Health Care, Medical | |
|
Novartis Venture Fund
VC Fund
|
1 | United States, Switzerland, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $5.1M–$107M |
|
PUSH VC
VC Fund
|
1 | Austria, Germany, United States | Seed, Pre-Seed, Series A | Software, Apps, Health Care | $650k–$31M |
|
NEOÏ S.à.r.l
VC Fund
|
1 | Austria | Series A | Medical, Analytics, Health Diagnostics | |
|
Algorithm Ltd
VC Fund
|
1 | Austria | Series A | Medical, Analytics, Health Diagnostics | |
|
Nova Capital Management
VC Fund
|
1 | United States, Italy, Canada | Series B, Seed, Series A | Software, Automotive, Health Care | |
|
Wellcome Trust
VC Fund
|
1 | United States, United Kingdom, France | Grant, Series C, Series B | Biotechnology, Health Care, Medical | $1.6M–$127M |
|
Santo Holding
VC Fund
|
1 | Germany, Austria | Venture - Series Unknown, Series B, Series C | Biotechnology, Energy, Medical | $7.7M–$10M |
|
Nina Capital
VC Fund
|
1 | United States, United Kingdom, Germany | Seed, Pre-Seed, Series A | Health Care, Artificial Intelligence, Software | $529k–$21M |
|
Biopart
VC Fund
|
1 | Austria | Series A | Medical, Analytics, Health Diagnostics | |
| Access all 138 investors in Austria Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
We invest in biotech and deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We are embedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.
Show more...Investment focus
- Industry: Biotechnology, Medical, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Austria, Germany, France
Investor stats
- Total investments: 49
- Round size: Seed $1.8M–$6.9M; Pre-Seed $552k–$1.8M; Series A $5.7M–$20M
- Lead/follow: 57% lead, 43% follow
Portfolio highlights
- PureSurf — PureSurf is a green chemistry company that develops bio-based surfactants and antimicrobial solutions for consumer and industrial markets.
- Rivus Batteries — Rivus is a start-up that serves as the commercialization platform for the aqueous organic flow battery technology.
- evasive robotics — EVASIVE ROBOTICS develops software and robotic systems for industrial automation. Its EvaLib technology coordinates multiple robots in shared workspaces and supports real-time motion planning. The company offers solutions for assembly, palletizing, bin picking, logistics, and intralogistics tasks. Its GESSBOT Duo platform combines a dual-arm automated guided vehicle with EvaLib software for handling, sorting, picking, and placing operations.
SOSV offers pre-seed capital and follow-on financial support to startups focusing on deep technology and scientific innovation. Founders utilize purpose-built laboratory facilities and engineering spaces to accelerate product development and testing. The firm facilitates connections between entrepreneurs and a network of investors through structured matchmaking events and technology summits.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, China, Canada
Investor stats
- Total investments: 3821
- Round size: Seed $125k–$5M; Pre-Seed $25k–$1.5M; Convertible Note $50k–$3.6M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely still investing — raised $306M in 2023
Portfolio highlights
- Halla — Halla Intelligence is a digital solution that leverages over 100 billion shopper and product data points to recommend and promote what grocery items.
- Verdex Technologies — Verdex Technologies is an advanced materials platform technology that uses nanofibers to disrupt industries. Verdex doesn't just compete, it innovates and disrupts.
- Samphire Neuroscience — Samphire Neuroscience builds clinically validated neurotechnology to support women across their lives. Our wearable devices, Nettle™ and Lutea™, are built on the same underlying brain-stimulation technology, targeting neural pathways involved in pain, mood, stress, and sleep regulation. - Lutea™ is available globally as a wellness device. Itstimulates the same regions of the brain to support stress regulation, sleep, and recovery - key drivers of readiness and long-term performance - allowing athletes and teams to move beyond wellbeing education alone to practical, evidence-based intervention. - Nettle™ is a CE-marked (EU and UK regulated), drug- and hormone-free device that has been clinically shown to improve pain, mood, functionality, and the ability to train during the menstrual cycle, with measurable benefits after one month of use - supporting athletes to maintain training intensity and movement quality during their period. - The Samphire App is the platform controlling all Samphire hardware products with the use of CycleSync™ AI technology: the only one of its kind to support personalized neurotechnology use for women.
Speedinvest is a globally active European venture capital firm built on a simple belief: many move more. From six offices across EMEA, our sector-focused investment teams back relentless founders from pre–Seed to Growth with long-term conviction, providing day-one access to our global network of corporate customers, experts, industry leaders, and top-tier follow-on investors to scale smarter and faster. Building lasting companies like Bitpanda (Austria), Moove (Nigeria), Gigs (U.S.), Tide (UK), ARX Robotics (Germany), Wayflyer (Ireland), GoStudent (Austria), Seqera Labs (Spain), and Cylib (Germany) — together. Big ideas may start with one. But scaling and winning take The Power of More.
Show more...Investment focus
- Industry: Software, FinTech, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, Germany, Austria
Investor stats
- Total investments: 684
- Round size: Seed $798k–$7.9M; Pre-Seed $411k–$3.8M; Series A $4.1M–$32M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — raised $372M in 2022
Portfolio highlights
- Findery — Find and leave notes anywhere in the world, discover local knowledge, hidden secrets, and exciting stories. Share your travel knowledge, geoblog, or local news!
- GAMINSIDE — GAMINSIDE revolutionizes your relationship with your customers. As European full service provider, we deliver the complete package with solutions, services and software for gamified loyalty that is tailor-made and unique to your products, brands and customers. Integrate the best ideas from gamification and customer loyalty in your business areato exceed your commercial targets with GAMINSIDE.
- Polaron — Polaron connects process, structure, and performance using AI and image data to accelerate how materials are characterised, designed, and manufactured.
We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.
Show more...Investment focus
- Industry: Biotechnology, Medical, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Austria, Slovenia
Investor stats
- Total investments: 22
- Round size: Seed $1.8M–$7.3M; Pre-Seed $552k–$1.5M; Series A $5.7M–$20M
- Lead/follow: 64% lead, 36% follow
Portfolio highlights
- subdron — subdron turns the seabed from a blind spot into a monitored domain.
- infrared.city — Redefine environmental simulations. Our bespoke AI models revolutionise performative design, slashing time, cost, and complexity. Access cutting-edge services effortlessly because innovation should be for everyone
- VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
APEX Ventures is a deep-tech and medical focused venture capital firm, run by founders with complimentary backgrounds driven by the same mission.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United Kingdom, Austria
Investor stats
- Total investments: 53
- Round size: Seed $1.4M–$8M; Pre-Seed $552k–$9.1M; Series A $2.4M–$22M
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- GEMESYS — Gemesys creates a chip that functions similarly to the human brain in order to overcome processing constraints and empower AI with the hardware it needs to complete its destiny
- HyperHeat — HyperHeat is building a cutting-edge, all-electric heating solution designed to reach temperatures of up to 2,000°C. Using renewable electricity HyperHeat is providing an efficient alternative to fossil fuel combustion. With an efficiency rate of up to 98%, HyperHeat is ideal for retrofitting industrial processes, enabling significant CO2reductions across industries like steel, cement, and chemicals. The scalable technology offers a cost-efficient approach to decarbonizing thermal processes, with a potential to reduce global CO2 emissions by over 4.5 gigatons annually.
- TriLite Technologies — The world's smallest projection displays from TriLite take laser beam scanning technology to the next level, for augmented vision as light as the eyewear of today.
ARAX Capital Partners is an Austrian bio-tech and high-tech early stage investor with an exclusive focus on Austrian ventures. Companies need to be young, innovative (if possible with patentable technology) and must have already secured pre-seed funding to qualify for an investment
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: Austria, United States
Investor stats
- Total investments: 24
- Round size: Seed $687k–$1.1M; Series A $2.8M–$11M; Venture - Series Unknown $325k–$1.8M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — raised $88M in 2008
Portfolio highlights
- Greenpass — Greenpass is an all-in-one SaaS for climate-resilient urban planning & architecture platform that enables livable cities.
- Calyxha Biotechnologies — A new perspective on inflammation
- EveliQure Biotechnologies GmbH — EveliQure was founded in 2012 with headquarters in Vienna and developed for the first time a combined vaccine, which is intended to protect against Shigella as well as against ETEC bacteria. Both bacterial strains cause various types of diarrheal diseases, and all attempts at development of vaccines have so far only aimed to protect against one ofthe two bacterial strains. The team led by Managing Director Gábor Somogyi has succeeded for the first time in producing a combined swallow vaccine that simultaneously protects against both bacterial strains.
We invest in B2B tech entrepreneurs who are obsessed with solving complex problems in huge markets at pre-seed and seed stage
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A, Series B
- Geography: Germany, United States, Poland
Investor stats
- Total investments: 88
- Round size: Seed $1M–$7.4M; Series A $3.2M–$20M; Series B $5M–$30M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely still investing — raised $84M in 2022
Portfolio highlights
- Procuros — More and more sales teams struggle with supplier portals. We help you integrate digitally with common supplier portals and consolidate all order documents.
- Flinn — We are driven to impact the health of millions of people around the globe by enabling medical companies to launch and operate products more efficiently. To make this vision come true, we established a customer-centric, experimentation-driven product development approach.
- Graph Therapeutics — Graph Therapeutics - precision immunology
Tecnet equity is an Austrian venture capital fund investing in new technology enterprises as well as companies with innovative business ideas through venture capital. As an early-stage investor, tecnet plays an active part in the Austrian start-up landscape for many years. The support tecnet provides goes far beyond a financial investment. With personal commitment, an international business network and many years of experience, tecnet support you in making your business successful. Active in the areas of information and communication technologies (ICT), life sciences, industrial technologies, material sciences and environmental technologies, tecnet equity is providing venture capital during seed and early stages. tecnet equity further supports the management teams of its portfolio companies in developing businesses that are fit for high and sustainable growth. Tecnet also offers comprehensive support to research centres and universities in the analysis, development and marketing of research results as well as patent protection. Inventions that are of value to society are offered to companies for implementation in new products generating additional business opportunities.
Show more...Investment focus
- Industry: Software, Biotechnology, Artificial Intelligence
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Austria
Investor stats
- Total investments: 76
- Round size: Seed $400k–$2.5M; Series A $557k–$20M; Venture - Series Unknown $208k–$3.5M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $33M in 2009
Portfolio highlights
- PROPCORN AI — At PROPCORN, our goal is to harness the power of AI to automatically unlock the full real estate building potential of our customers, enabling them to make faster and more accurate decisions in real-time.
- deepentix — Deepentix provides a graph-as-a-service platform that converts unstructured documents into verifiable claim graphs. Its software extracts semantic claims, qualifiers, constraints, and confidence information, then links entities to domain ontologies. The Claim Graph API supports natural-language and API-based queries with paragraph-level citations,conflict flags, policy checks, and provenance paths. Private extractors use domain-tuned small language models for organization-specific templates and terminology. Deepentix also offers hosted and on-premises graph deployments that can integrate with systems such as electronic laboratory notebooks, laboratory information management systems, claims systems, and chat copilots. The platform is intended for regulated workflows in life sciences, insurance, legal and regulatory work, and climate and ESG analysis where document-based decisions require traceability and audit records.
- VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
The Austrian Economic Service mbH (aws) is the promotional bank of the Federal Government. The aws SME fund is the largest Austrian Fund for silent corporate investments, but also providers of equity. Founded in late 2009 by the Austrian Economic Service mbH (aws) - the Development Bank of the Federal - he has a term until 31/12/2025. The fund is currently endowed with EUR 80 million and participates in medium-sized companies and brings with it a fresh capital to develop new products or processes, for sales development to international expansion.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Grant, Pre-Seed
- Geography: Austria, Belgium, Philippines
Investor stats
- Total investments: 77
- Round size: Seed $452k–$2.7M; Grant $61k–$2.3M; Pre-Seed $195k–$1.6M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $92M in 2013
Portfolio highlights
- DiLT Analytics — DiLT Analytics develops AI-based software and analytics solutions for intelligent building operations and energy systems. The company focuses on using monitoring data, machine learning, and logic-based diagnosis to reduce energy consumption and improve building performance. Its offerings include tools for fault detection, anomaly detection, and control strategy optimization in complex heating, ventilation, and air conditioning systems. DiLT Analytics also participates in collaborative research projects on causal AI, physics-informed machine learning, predictive maintenance, and smart energy services. These activities support building owners, operators, and industry partners in implementing data-driven building management and energy-efficient operation strategies.
- Graph Therapeutics — Graph Therapeutics - precision immunology
- Epitome Therapeutics — Epitome Therapeutics is an early-stage biotechnology company developing CADENCE, a next-generation epigenome editing platform for precise, durable, and context-dependent control of gene expression without altering the underlying DNA sequence, with the aim of establishing a new therapeutic modality for diseases driven by dysregulated gene activity.
Austria Wirtschaftsservice is an investment firm.
Show more...Investment focus
- Industry: Medical, Machine Learning, Artificial Intelligence
- Stage:Seed, Pre-Seed, Grant
- Geography: Austria, Philippines
Investor stats
- Total investments: 8
- Round size: Seed $751k–$2.3M; Pre-Seed $510k–$1.6M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- S2data — Revolutioniere deine Lieferkette mit intelligenter Logistik. Effiziente Transporte durch bahnbrechende Algorithmen & einzigartige Software.
- Syntropic Medical — Syntropic is a medical device company that develops novel technologies that helps for the treatment of psychiatric diseases and the improvement of cognitive abilities.
- Cycuria Therapeutics — While new therapies, such as FLT3 inhibitors and venetoclax-based regimens, have improved initial response rates, durable remissions and long-term survival
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!The Austrian Research Promotion Agency (FFG) is the national funding agency for industrial research and development in Austria. As a "one-stop shop" offering a diversified and targeted programme portfolio, the FFG gives Austrian businesses and research facilities quick and uncomplicated access to research funding. The FFG was founded on 1 September 2004 (pursuant to the FFG Act on establishing a research promotion agency, Federal Law Gazette I No. 73/2004). The FFG is wholly owned by the Republic of Austria, represented by the Federal Ministry for Transport, Innovation and Technology (bmvit) and the Federal Ministry of Science, Research and Economy (BMWFW). As a provider of funding services, however, the FFG also works for other national and international institutions.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Medical
- Stage:Grant, Seed, Pre-Seed
- Geography: Austria, United States, Belgium
Investor stats
- Total investments: 75
- Round size: Seed $745k–$2.8M; Grant $67k–$2.5M; Pre-Seed $480k–$1.9M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Another Earth — Synthetic Earth observation data that trains AI models to simulate environmental change and predict risk before it happens. Vienna-based, founded 2024.
- Graph Therapeutics — Graph Therapeutics - precision immunology
- Epitome Therapeutics — Epitome Therapeutics is an early-stage biotechnology company developing CADENCE, a next-generation epigenome editing platform for precise, durable, and context-dependent control of gene expression without altering the underlying DNA sequence, with the aim of establishing a new therapeutic modality for diseases driven by dysregulated gene activity.
Cherry Ventures is Europe’s leading early-stage venture capital firm led by a team of founders and operators with experience building fast-scaling companies such as Spotify, Zalando, and Uber. The firm backs Europe's boldest founders, usually as their first institutional investor, and supports them in everything from go-to-market strategy, scaling the business, and team formation across all crucial stages in their journey. We look for founders with a vision to create revolutionary technologies - whether it’s AI, healthcare, robotics, consumer, or others - that impact society and change the world for the better. Cherry has invested in the pre-seed and seed stages of over 130 companies across Europe, including Flix, Auto1, Flaschenpost, Amboss, Manual, Numa, Moss, The Exploration Company, Qualifyze, Swap, Dash0, Proxima Fusion and Tacto. Cherry has offices in Berlin, London, and Stockholm. www.cherry.vc
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United Kingdom, United States
Investor stats
- Total investments: 302
- Round size: Seed $1.9M–$14M; Pre-Seed $1.1M–$6.6M; Series A $7.3M–$44M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely actively investing — fresh fund, raised $500M in 2025
Portfolio highlights
- RobCo — Easily automate the repetitive tasks in your production facility with modular industrial robots from RobCo.
- Spiich Labs — AI for revenue teams that win on relationships. Spiich preps your meetings, updates your CRM and drafts follow-ups. Reps save 9+ hours every week.
- Integral — Bookkeeping, financial statements, and payroll all from one source
MMV is a multistage, global venture capital firm investing in enterprise software, cybersecurity, financial technology, and digital health companies. We help accelerate the growth of the companies we partner with by providing capital, connections and advice.
Show more...Investment focus
- Industry: Financial Services, Software, Information Technology
- Stage:Series A, Series B, Seed
- Geography: United States, Singapore, India
Investor stats
- Total investments: 161
- Round size: Seed $2.7M–$11M; Series A $5M–$23M; Series B $7M–$50M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely actively investing — fresh fund, raised $150M in 2026
Portfolio highlights
- Kivo Health — Kivo Health is a telehealth lung care company that provides rehab for chronic lung disease.
- AGent Energy — AGent Energy operates a hardware and software platform that connects commercial, industrial, and institutional backup generators and other distributed energy resources to electricity markets. The company installs onsite equipment and software, monitors generator condition and utilization, and manages participation in demand-response and other gridprograms. Its platform supports remote dispatch, operational alerts, anomaly detection, compliance processes, and diagnostic data for facilities such as hospitals, manufacturers, data centers, universities, agricultural sites, retailers, and water infrastructure operators. AGent Energy shares market proceeds with participating facility owners while maintaining generator availability for backup use.
- EduFund — EduFund is India's leading education finance platform, helping parents plan, save, and pay for their child's higher education, in India or abroad. Co-founded in 2020 by Eela Dubey and Arindam Sengupta, EduFund was built on a simple conviction: most Indian families focus intensely on academic preparation for college and almost entirelyignore the financial side until it's too late. Eela Dubey, Co-founder and CEO, is a NYU graduate with a background in hedge funds on Wall Street. Arindam Sengupta, Co-founder, is a Princeton University alumnus with experience at Citadel and Reliance Capital. Together, they built EduFund to close the gap between being academically ready and financially ready for higher education. The platform offers a full suite of education finance tools, including mutual fund SIPs, fixed deposits, digital gold, and term insurance, alongside education loans, scholarship discovery, and end-to-end admissions support. Its AI-powered college cost calculator, Taara, gives parents inflation-adjusted cost estimates across 3,000+ colleges in 19+ countries in seconds, factoring in tuition, living costs, and currency risk. EduFund started out as a B2C app for consumers. EduFund's B2B platform, Vittam, serves to scale the same mission through India's MFD ecosystem, enabling wealth distributors to offer their clients a broader suite of financial products, from education loans and GIFT City funds to EB-5 global investment products and international health insurance. EduFund has served 250,000+ families and built a partner network of 40+ asset management firms and 15+ lending institutions, along with over 300 MFDs and IFA's through it's B2B vertical, Vittam. EduFund has raised $12 million in total funding, including a $6 million Series A led by Cercano Management and MassMutual Ventures. The company is also supported by angel investors.
SkyGene is a venture capital firm. The firm intends to invest in biotech firms.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Venture - Series Unknown
- Geography: Austria
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
Rene Schneider
Show more...Investment focus
- Industry: Medical, Analytics, Health Diagnostics
- Stage:Seed, Series A
- Geography: Austria
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that helps people understand their health by explaining their medical reports and health data to them in a personalized, easy-to-understand, and visual way.Through its consumer apps and enterprise software, Medicus is focused on bringing meaning to data, by helping patients and users understand theirhealth, and augmenting the roles of doctors, midwives, and other healthcare providers through innovative data visualization, patient communication, and remote monitoring tools.
VP Venture Partners is a venture capital firm invests in healthcare companies.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed, Pre-Seed, Series B
- Geography: Austria, Germany, Switzerland
Investor stats
- Total investments: 7
- Round size: Seed $3M–$6.9M; Series B $7.5M–$16M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Diamens — Diamens is a company focused on femtech that develops a non-invasive menstrual blood-based molecular diagnostic to detect women-specific diseases like endometriosis.
- Moonlight AI — Moonlight AI was created to democratize the access to genomic information that is essential for therapy decision making in the era of personalized medicine.
- CollimateHealth — CollimateHealth is creating a clinically scalable microbeam radiation technology that will revolutionize the treatment of cancer.
Investment Company
Show more...Investment focus
- Industry: Medical, Analytics, Health Diagnostics
- Stage:Seed, Series A
- Geography: Austria
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that helps people understand their health by explaining their medical reports and health data to them in a personalized, easy-to-understand, and visual way.Through its consumer apps and enterprise software, Medicus is focused on bringing meaning to data, by helping patients and users understand theirhealth, and augmenting the roles of doctors, midwives, and other healthcare providers through innovative data visualization, patient communication, and remote monitoring tools.
aws Gründerfonds is Austria's 140m venture capital fund. We invest in Austrian high-growth start-ups in their later seed and (pre-)series-A stages.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Austria, Germany, United States
Investor stats
- Total investments: 101
- Round size: Seed $1.3M–$5.2M; Series A $1.1M–$11M; Venture - Series Unknown $1.9M–$3.4M
- Lead/follow: 14% lead, 86% follow
- Last fund: Likely still investing — raised $77M in 2023
Portfolio highlights
- refinq — Score every location for physical climate, nature and transition risk under IPCC scenarios, and link exposure to financial impact and adaptation actions.
- profitize — profitize is an AI‑powered financial planning and analysis (FP&A) platform built specifically for hotels and other hospitality businesses.The platform uses AI to generate forecasts, highlight risks, and provide actionable insights, positioning itself as an “FP&A co‑pilot” for hotel profitability rather than just a reporting tool.
- Invisible-Light Labs — Invisible Light Labs uses Fourier transform infrared (FTIR) spectroscopy and nanoelectromechanical sensing technologies to enable chemical analysis of materials and nanomaterials that are available in minuscule amounts in a variety of industries, from environmental monitoring to pharmaceuticals.
Kinled was founded in 1980 to retain the investment assets of the Aisher family. In 1990, the investment focus shifted to a portfolio of early stage investments applying Kinled’s company development experience alongside the endurance and passion of family owned investments together with the strategic focus of venture capitalists. Since then, Kinled has taken 8 companies to public markets and many more to successful trade sales at significant multiples.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: United Kingdom, United States, Switzerland
Investor stats
- Total investments: 144
- Round size: Seed $594k–$14M; Series A $1.7M–$40M; Venture - Series Unknown $1.6M–$13M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Esper — Esper is the first cloud-based platform to help governments proactively manage public policy with better data and transparency.
- Varda — Expanding the economic bounds of humankind with the world's first orbital manufacturing & reentry platform.
- TAG Therapeutics — TAG Therapeutics develops precision medicine approaches for telomere pathologies and aging-related diseases, such as Idiopathic Pulmonary Fibrosis and Short Telomere Syndromes
Investment Company
Show more...Investment focus
- Industry: Medical, Analytics, Health Diagnostics
- Stage:Seed, Series A
- Geography: Austria
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that helps people understand their health by explaining their medical reports and health data to them in a personalized, easy-to-understand, and visual way.Through its consumer apps and enterprise software, Medicus is focused on bringing meaning to data, by helping patients and users understand theirhealth, and augmenting the roles of doctors, midwives, and other healthcare providers through innovative data visualization, patient communication, and remote monitoring tools.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Founding GP @SDAC Ventures. Formerly product @N26 and @Taxfix, strategy @HEC, org theory @ZeppelinUni and Ethereum @ETHBerlin.
Show more...Investment focus
- Industry: Blockchain, Sports, Battery
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, United Kingdom, Austria
Investor stats
- Total investments: 9
- Round size: Seed $2M–$7.5M; Pre-Seed $1.1M–$3.5M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Tromero — Tromero - cost effective Machine Learning Training & Hosting
- Cardino — Cardino - Verkaufen Sie Ihr E-Auto digital zum besten Preis. Entdecken Sie die einfache und bequeme Art, Ihr Elektroauto online zu verkaufen.
- Flinn — We are driven to impact the health of millions of people around the globe by enabling medical companies to launch and operate products more efficiently. To make this vision come true, we established a customer-centric, experimentation-driven product development approach.
Johann Hansmann is based out of Vienna, Vienna and currently works as a Chairman for Hansmann Family Office. Johann previously worked at tractive as a Partner and Advisor. Johann Hansmann attended WU (Vienna University of Economics and Business).
Show more...Investment focus
- Industry: Software, Health Care, Fitness
- Stage:Seed, Angel, Pre-Seed
- Geography: Austria, United Kingdom, Germany
Investor stats
- Total investments: 73
- Round size: Seed $300k–$3.4M; Angel $350k–$630k; Pre-Seed $439k–$2.8M
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- fynk — Create, edit, negotiate and sign contracts quickly with fynk. Give your team back valuable time. Test it now for free!
- Newsrooms.ai — Newsrooms.ai is an AI-powered content production and management platform that enables businesses and news organizations to automate their whole content pipeline—from research and content generation to publishing across many digital channels.
- Donnerstag.ai — Donnerstag automates finance operations with AI: AR, AP and bank reconciliation at line-item level, exception handling and a full audit trail.
As a physician, I cherished every life touched, every suffering eased; yet I yearned for more - a greater, scalable social impact. I dreamt of a world where my own reach was not limited by the confines of time or distance, where every doctor could harness the power of technology to multiply their healing touch. Today, this dream takes shape throughour breath diagnostics company, where we strive to equip hundreds of thousands of doctors worldwide with our pioneering technology, thereby transforming patient care. We are crafting a future where technology and compassion converge, redefining the boundaries of what we, as physicians, can achieve for our patients.
Show more...Investment focus
- Industry: Medical, Medical Device
- Stage:Seed, Pre-Seed
- Geography: Austria
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Flinn — We are driven to impact the health of millions of people around the globe by enabling medical companies to launch and operate products more efficiently. To make this vision come true, we established a customer-centric, experimentation-driven product development approach.
bmp Ventures is an innovative Venture Capital Company from Berlin. Since 1997 we’ve been investing Smart Money in Early Stage and Growth Startups. We finance ingenious business models with outstanding teams, who build fast-growing and sustainably profitable enterprises.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Germany, United States, Austria
Investor stats
- Total investments: 122
- Round size: Seed $162k–$3.6M; Series A $1.1M–$5.9M; Venture - Series Unknown $172k–$12M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — raised $70M in 2024
Portfolio highlights
- Lab Thunder — LabThunder provides a cloud-based laboratory management software platform designed to digitize operational workflows. The system centers on centralizing equipment management, automated maintenance scheduling, digital logbooks, and AI-supported knowledge management to ensure audit-ready compliance.
- Sedivention — Fight obesity within 20 minutes - fast, effective, long-term. A new weight-loss therapy for the treatment of obesity. Just a view minutes will change your life.
- Solar Materials — Solar Materials primarily engages in the development of technologies for the sustainable and economical recycling of solar modules.
A genetic medicines company developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Post-IPO Debt, Corporate Round, Post-IPO Equity
- Geography: United States, Austria, Denmark
Investor stats
- Total investments: 21
- Round size: Post-IPO Debt $15M–$85M; Corporate Round $3M–$10M; Post-IPO Equity $15M–$90M
- Lead/follow: 57% lead, 43% follow
Portfolio highlights
- AvenCell — Next generation immunotherapies for hard-to-treat cancers that are allogeneic and switchable.
- Primrose Bio — Primrose Bio develops and commercializes manufacturing technologies that close gaps in biologics, mRNA and vaccine production.
- Castle Creek Biosciences — Dedicated to making life better for people suffering from rare diseases with few or no treatment options
Entrepreneurs for Entrepreneurs
Show more...Investment focus
- Industry: Software, Information Technology, Automotive
- Stage:Seed, Series A, Series B
- Geography: Austria, Germany, Switzerland
Investor stats
- Total investments: 67
- Round size: Seed $540k–$1.2M; Series A $781k–$5.6M; Series B $4.2M–$13M
- Lead/follow: 78% lead, 22% follow
Portfolio highlights
- Diamens — Diamens is a company focused on femtech that develops a non-invasive menstrual blood-based molecular diagnostic to detect women-specific diseases like endometriosis.
- Respory — Make customer behaviour visible across your store and turn real customer journeys and interactions into better retail decisions.
- 2nd Cycle — 2nd Cycle creating a cost-effective, fully automated, and scalable solution for modules for a second life cycle.
HV Capital operates as a venture capital firm that invests in technology startups across Europe at all stages, from early seed funding to growth investments. The firm partners with founders to support company development over the long term, providing capital, strategic guidance, and access to its network. HV Capital invests across sectors such as software, fintech, healthcare, and consumer technology, and supports companies throughout multiple funding rounds
Show more...Investment focus
- Industry: E-Commerce, Software, Internet
- Stage:Series A, Seed, Series B
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 518
- Round size: Seed $1.5M–$13M; Series A $3.6M–$35M; Series B $7.5M–$75M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — raised $783M in 2023
Portfolio highlights
- Exein — Exein develops embedded cybersecurity solutions designed to secure Internet of Things (IoT) and connected devices. The company provides a platform that integrates security directly into the firmware of embedded systems, enabling real-time threat detection, monitoring, and response. Exein’s technology focuses on runtime protection and behavioranalysis at the edge, helping manufacturers secure devices without requiring major hardware changes or external software agents. Its solution is compatible with widely used real-time operating systems (RTOS) and Linux-based environments, allowing for flexible integration across different devices. The company also offers tools for vulnerability assessment and threat intelligence tailored for firmware-level defense. Exein supports developers with APIs and SDKs to incorporate security features during the product development phase. Through its platform, the company addresses growing security risks in critical sectors such as automotive, industrial automation, and consumer electronics.
- Rivercell — Rivercell develops a proprietary, programmable laboratory data platform alongside an artificial intelligence world model of the human cell to map and analyze therapeutic cellular responses. The integrated framework combines automated longitudinal, multimodal, and perturbational wet-lab testing to collect high-resolution datasets measuring how living tissue changes over time under specific treatments. Its value proposition is centered on serving as a cross-disease discovery engine that accelerates and de-risks drug development by accurately forecasting cellular mutations, clinical efficacy, and treatment resistance in silico.
- Rabot Energy — Rabot Charge offers intelligent charging management solutions for customers to charge their electric cars at home.
MMC is an early-stage venture capital fund investing in exceptional entrepreneurs across Europe.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 274
- Round size: Seed $1.6M–$10M; Series A $2.9M–$19M; Series B $10M–$54M
- Lead/follow: 37% lead, 63% follow
- Last fund: May invest from a new fund soon — raised $129M in 2019
Portfolio highlights
- Ravical — Ravical equips professional services firms with AI agents that collaborate and scale, unlocking practical value today and future growth tomorrow.
- ABEX — Algorithmic Best Execution for Digital Assets
- Stanhope AI — Stanhope AI is a deep-tech startup based in London with a strong background in neuroscience, robotics and fintech. We are bringing Active Inference to market as a novel framework for autonomous decision-making. To contend with the challenges of contemporary AIs, our distinct approach aims to offer
Multi family office investing in proptech, digital health & sustainability
Show more...Investment focus
- Industry: Health Care, Medical, Health Diagnostics
- Stage:Seed, Series A, Pre-Seed
- Geography: Austria, Germany
Investor stats
- Total investments: 10
- Round size: Seed $165k–$658k; Series A $2.4M–$6.5M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Greenpass — Greenpass is an all-in-one SaaS for climate-resilient urban planning & architecture platform that enables livable cities.
- Kranus Health — Kranus Health is a global provider for Men‘s Health Prescription Digital Therapeutics (PDTs). Our therapies make millions of men live a better and longer life and enable doctors to treat their patients more efficiently.
- HelloBello — HelloBello offers freshly cooked and cooled delivered human-grade food tailored to each dog’s nutritional needs. HelloBello is a PetTech company with a strong focus on the German speaking markets (for now). HelloBello’s personalized meals are free of any by-products and are portioned, packaged, and delivered directly to your door. By working with aspecialized veterinarian, HelloBello is able to derive each dog’s exact nutritional needs based on a proprietary algorithm. The recipes are made of natural sources like millet and seaweed, instead of heavy use of supplements, which makes it easier for the dog to absorb and get true nutritional benefits.Our credo in German is " ... Frisch. Individuell. Geliefert. - Frischfutter ist einfach besser ..."
Investor
Show more...Investment focus
- Industry: Medical, Analytics, Health Diagnostics
- Stage:Angel, Series A
- Geography: Austria
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that helps people understand their health by explaining their medical reports and health data to them in a personalized, easy-to-understand, and visual way.Through its consumer apps and enterprise software, Medicus is focused on bringing meaning to data, by helping patients and users understand theirhealth, and augmenting the roles of doctors, midwives, and other healthcare providers through innovative data visualization, patient communication, and remote monitoring tools.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!MIG Capital is one of the leading German VC Investors. We invest in European Deep Tech and Life Sciences from early to late stage (Seed, Series A, and beyond). We use investments to shape a better tomorrow, today. Our team currently manages 17 MIG public venture capital funds regulated by BaFin, the German financial markets authority. These funds operate with more than EUR 1.2 billion capital committed by >60,000 private investors across Germany and Austria. Today, our portfolio consists of 30 companies.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: Germany, France, Austria
Investor stats
- Total investments: 98
- Round size: Series A $2.2M–$40M; Series B $1.7M–$60M; Venture - Series Unknown $5.6M–$20M
- Lead/follow: 45% lead, 55% follow
- Last fund: May invest from a new fund soon — raised $76M in 2014
Portfolio highlights
- NcodiN — The High Performance Computing (HPC) and ArtificiaI Intelligence (AI) era requires unprecedented computing capabilities. With this in view, industry is heading towards zettascale supercomputers, based on >100k processing units. Chiplets-based disaggregated processors and memory-centric computing architectures are taking over and require an ever more intensive communication between dies. Thus, today interconnect bottleneck is the main
- GlassPoint Solar — GlassPoint provides solar steam generators to the oil and gas industry for applications such as Enhanced Oil Recovery. It replaces gas-fired steam generation with solar, GlassPoint can reduce EOR gas consumption by up to 80 percent. The company was founded in 2008 and headquartered in Fremont, California.
- Zadient Technologies — Zadient produces semiconductor manufacturing materials that are critical for the entire silicon carbide (SiC) value chain
LANA Ventures is a venture capital firm.
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Seed, Pre-Seed
- Geography: Austria, Germany
Investor stats
- Total investments: 5
- Round size: Seed $2.8M–$7.4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- XUND — Answer the most important health questions with AI-powered technology from XUND. Medically certified and CE marked.
- UniteLabs — UniteLabs provides the foundational operating system for AI-driven lab automation in life science. It accelerates scientific discovery by closing the loop with a unified data and automation infrastructure, seamless integration, and intelligent control. Our platform empowers ambitious biotech companies, big pharma, integrators, and hardware vendorsby offering bidirectional connectors for diverse lab equipment, a scalable cloud platform with an open API, and a powerful workflow engine with an integrated compute environment. This allows for the creation of sophisticated, modular workflows, and enables rapid automation development through our Lab-as-Code environment, featuring a dynamic Python SDK and application-specific libraries.
- Aitiologic — A precision medicine startup providing multi-modal liquid biopsy solutions for early disease detection and targeted therapy.
GLS Ventures
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series B
- Geography: Austria
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Nabriva Therapeutics — MPOMM Adalah link resmi berlisensi agen mpo slot paling gacor hari ini dengan pilihan bermain di server slot anti rungkat terjamin kemenangan jackpot maxwin menang berapapun akan di bayar lunas
TBA Network provides risk capital, entrepreneurial expertise, and valuable network support to ambitious founders. TBA objective is to support innovative ideas and contribute to the global expansion of early-stage startups, laying the groundwork for future entrepreneurs.
Show more...Investment focus
- Industry: Apps, Medical, mHealth
- Stage:Seed
- Geography: Austria, Italy
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- XUND — Answer the most important health questions with AI-powered technology from XUND. Medically certified and CE marked.
- Tree.ly — Tree.ly does climate protection through the projects in European forests through its SaaS platform and hyperlocal CO2-credits.
- ALLSIDES — Covision Media specializes in creating high-quality, relightable 3D models using their industrial 3D scanners. These scanners capture detailed surface information and PBR textures, and are designed for easy integration into virtual environments.
redalpine is a thesis-driven vc with deep expertise in software and science. since 2006. we believe in the power of big ideas and in empowering game changers. we don't just invest, we co-create a better tomorrow. together with you.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A, Series B
- Geography: Germany, Switzerland, United Kingdom
Investor stats
- Total investments: 167
- Lead/follow: no public data
Portfolio highlights
- Inkitt — Publish stories online, join our author subscription program, and read books online for free. Join the Inkitt community for writers and readers today.
- Donut — Donut helps people discover new ways to build wealth, by providing the easiest and most trusted way to save & earn high yield with DeFi. Donut was founded in 2018 and is dual headquartered in Los Angeles and Berlin.
- Umiami — Umiami Technologies is a leader in plant-based meat. Our proprietary technology allows us to create clean-label and incredibly tasty foods.
Techno Venture Management is a venture capital and private equity firm focused on healthcare industry.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series B, Series A
- Geography: United States, Germany, United Kingdom
Investor stats
- Total investments: 99
- Round size: Series A $4.7M–$22M; Series B $5.2M–$44M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Streaming21 — Streaming21 is a solution provider of seamless on-demand and IP broadcasting service platform for connected digital home.
- Helomics — Helomics® is a comprehensive personalized healthcare company, bringing the next generation of diagnostics to the oncology field. Helomics is dedicated to improving patient outcomes by providing a personalized comprehensive tumor profile utilizing a proprietary set of laboratory platforms that leverage both tissue-based live and fixed cellular basedanalysis allowing physicians to characterize malignant tumors on a personalized basis. Helomics’ novel molecular and cellular markers and bioinformatics services support treatment decisions by providing vital information based on the specific biological processes of each individual’s cancer.
- Precision Therapeutics — Precision Therapeutics is a pharmaceutical research and development business that develops personalized cancer treatments for patients.
Lead Ventures is a Budapest-based venture capital firm, specialist of financing scale-ups in Central Europe. Its mission is to support the region’s most promising ventures with capital, experience and a wide-ranging professional network, enabling them to transform their industry with innovation. Lead Ventures provides equity financing tocompanies in their scale-up phase, the typical ticket size is between EUR 2-10 million. Lead Ventures is searching for dynamic teams with a unique story, outstanding growth potential and solutions tested and validated by the market. The firm seeks to invest in companies operating in the mobility, energy and sustainability as well as b2b services and software sectors, however, Lead Ventures is open to support teams active in other areas as well.Lead Ventures has EUR 200 million under management invested by MOL, the most successful energy company in CEE, and two financial institutions specialised in supporting the startup ecosystem - the Hungarian Development Bank (MFB) and Eximbank.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: Hungary, United Kingdom, Croatia
Investor stats
- Total investments: 27
- Lead/follow: no public data
Portfolio highlights
- Oxla — Meet Oxla, the world's fastest-distributed database, designed to handle large amounts of data with ease.
- XUND — Answer the most important health questions with AI-powered technology from XUND. Medically certified and CE marked.
- RedTrack.io — RedTrack.io offers real-time access to your media buying KPIs/data: ad tracking, impressions, clicks, conversions across multiple channels & 30 data points.
New generation venture capital investing into combinatorial technologies
Show more...Investment focus
- Industry: Artificial Intelligence, Information Technology, Machine Learning
- Stage:Pre-Seed, Seed
- Geography: Czech Republic, United States, United Kingdom
Investor stats
- Total investments: 19
- Lead/follow: no public data
Portfolio highlights
- Wultra — Wultra helps the leading banks and fintech companies to secure their digital systems and bring trust to the customer journeys. Our security-related software technologies cover the whole digital banking application stack, be it on the web or mobile platforms.
- Openvibe — Interact With Anyone On The Open Internet. All Decentralised Social Networks, Single Timeline.
- Edmund — Edmund is an enterprise level system that interconnects all manufacturing technologies, providing a comprehensive view of entire factory.
IT-Farm is a venture capital firm which specializes in seed, start-up, and early stage companies. It primarily invests in mobile, big-data, connected car, IoT, OTT service, Helth care, Bio Tech and other IT industries. The firm actively invests in SF bay area and Japan, as well as other geometries including Asia and Europe. We support portfoliocompanies, especially on the partnership with Japanese enterprises.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Seed, Series A
- Geography: United States, Japan, Germany
Investor stats
- Total investments: 120
- Round size: Seed $1.8M–$9.3M; Series A $1.8M–$20M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- BitBiome — BitBiome is a microbiome analysis company that aims to discover and understand disease-linked microorganisms. Its, single-cell whole-genome analysis platform specifically targets microbes and can be used on uncultured, raw samples, providing unprecedented strain-level quantitative and functional insights.THe company was founded in 2018 and isbased in Japan.
- TopoLogic — TopoLogic designs and manufactures heat flow sensors, thermoelectric conversion devices, and topological and novel spintronics materials.
- Global Equipment Services — As a strategic partner to developers of multi-sector products, Averna provides innovative automated testing tool and quality assurance solutions.
HBM Partners focuses on venture, growth and buy-out financings of private companies as well as investments in public companies.The HBM funds invest in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. Their team supports the growth of the portfolio companies through all stages of development, focusing on adding value by leveraging its experience and HBM's world-wide network in the industry. Investments usually range between $5 million to $50 million.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series C, Convertible Note
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 59
- Round size: Series B $7.7M–$125M; Series C $2.5M–$111M; Convertible Note $600k–$4.3M
- Lead/follow: 15% lead, 85% follow
- Last fund: May invest from a new fund soon — raised $118M in 2012
Portfolio highlights
- Fore Biotherapeutics — We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
- Upstream Bio — Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma. They are clinical-stage monoclonal antibodies that inhibit the TSLP receptor, a validated target located upstream of various signaling cascades that influence a range of immune cells that are important in common and unusual illnesses.
- AtaiBeckley — We are a clinical-stage biopharmaceutical company developing new mental health treatments to transform patient outcomes.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!We are i&i Biotech Fund, partners of outstanding founders on their path to global success. We invest in innovative early stage Life Sciences startups.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A
- Geography: Czech Republic, India, Spain
Investor stats
- Total investments: 10
- Lead/follow: no public data
Portfolio highlights
- Antiverse — Designing biologics for 100 challenging targets
- Captain T Cell — Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients. The company identifies novel high-efficiency TCRs for the development of T cell immunotherapies. It focuses on CMC- and preclinical development for their lead candidates.
- Casinvent Pharma — Casinvent Pharma develops new therapeutic options for the treatment of selected malignancies.
Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, Switzerland, United Kingdom
Investor stats
- Total investments: 247
- Round size: Series A $5.1M–$81M; Series B $11M–$107M; Series C $9M–$75M
- Lead/follow: 26% lead, 74% follow
- Last fund: May invest from a new fund soon — raised $200M in 2009
Portfolio highlights
- Kynexis — Kynexis is leading the way in precision medicine, focusing on the treatment of cognitive impairment associated with schizophrenia (CIAS). Explore our innovative approach and our dedication to improving the lives of millions globally.
- Visiogen — Visiogen, Inc. is an ophthalmic medical device company specializing in the development of new vision alternatives for patients with cataracts, with and without presbyopia. As part of this mission, Visiogen created the Synchrony dual optic accommodating *intraocular lens (IOL)* for use in the surgical treatment of these conditions.The device isdesigned to provide patients with near, intermediate and distance vision in a seamless continuum without the need for glasses or contact lenses. To eliminate lens handling during surgery, the Synchrony dual optic IOL is provided in a pre-loaded injector. This patented technology has been approved in Europe with a CE Mark designation and is currently undergoing clinical trials in the United States.
- Rein Therapeutics — Harnessing fibrosis, unleashing life
Early-stage VC. Pre-Seed and Seed stage. We are investing in Health- & Green Tech start-ups with singificant impact and outstanding teams.
Show more...Investment focus
- Industry: Software, Apps, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: Austria, Germany, United States
Investor stats
- Total investments: 46
- Round size: Seed $650k–$8.1M; Series A $5M–$31M
- Lead/follow: 17% lead, 83% follow
- Last fund: May invest from a new fund soon — raised $11M in 2019
Portfolio highlights
- Voltrac — To Secure Our Borders and Food Supply.
- enspired — Revolutionize battery storage with AI-powered BESS optimization. Our energy trading platform ensures smart, real-time market access. Contact us today!
- Aitiologic — A precision medicine startup providing multi-modal liquid biopsy solutions for early disease detection and targeted therapy.
Investment Company
Show more...Investment focus
- Industry: Medical, Analytics, Health Diagnostics
- Stage:Series A
- Geography: Austria
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that helps people understand their health by explaining their medical reports and health data to them in a personalized, easy-to-understand, and visual way.Through its consumer apps and enterprise software, Medicus is focused on bringing meaning to data, by helping patients and users understand theirhealth, and augmenting the roles of doctors, midwives, and other healthcare providers through innovative data visualization, patient communication, and remote monitoring tools.
Investment Company
Show more...Investment focus
- Industry: Medical, Analytics, Health Diagnostics
- Stage:Series A
- Geography: Austria
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that helps people understand their health by explaining their medical reports and health data to them in a personalized, easy-to-understand, and visual way.Through its consumer apps and enterprise software, Medicus is focused on bringing meaning to data, by helping patients and users understand theirhealth, and augmenting the roles of doctors, midwives, and other healthcare providers through innovative data visualization, patient communication, and remote monitoring tools.
The typical market transaction involves the sale of one company at a time. However, there are situations where disposing of holdings in a number of businesses, in a single transaction, brings significant benefits - together with substantial time and cost efficiencies.Whether seeking a solution to illiquidity, the disposal of legacy assets orthe freedom to implement strategic change, Nova offers the corporate and financial sellers an efficient and market value solution. Unlocked from their holdings, investors and owners are better positioned to focus on the benefits and opportunities this significant step change brings.Although principally an acquirer, Nova can also work with investors in private equity funds, where there is the need for a Replacement Manager or General Partner.
Show more...Investment focus
- Industry: Software, Automotive, Health Care
- Stage:Series B, Seed, Series A
- Geography: United States, Italy, Canada
Investor stats
- Total investments: 8
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Roboze — Roboze is able to engineer high performance thermoplastic polymers resistant to the most extreme operating conditions for various sectors.
- Glow LifeTech — Glow LifeTech is a Canadian-based biotechnology company focused on producing nutraceutical and cannabinoid-based products with dramatically enhanced bioavailability, absorption and effectiveness. Glow has rights to the groundbreaking, plant-based MyCell Technology® delivery system, which transforms poorly absorbed natural compounds into enhancedwater-compatible concentrates, unlocking the full healing potential of natural active compounds.
- Aqua Membranes — Aqua Membranes is revolutionizing RO membrane filtration with its unique printed spacer technology. The Polymer is applied directly to the flat sheet membrane to create a customized raised pattern that replaces conventional extruded mesh feed spacers. Unlike traditional membrane spacers that trap particles and biofilm within the spacer mesh andthereby obstruct flow, the printed dimensional spacers optimize flow patterns and turbulence throughout the membrane element, minimizing the entrapment of particulates and organic fouling. Printed spacer technology also increases permeate flow, improves flux and recovery, minimizes system pressure drop, and extends the operational life of a membrane element.Aqua Membranes' unique technology is perfect for spiral-wound membrane manufacturers eager to improve their product performance and whose customers demand more durable, low maintenance elements that can withstand challenging feed streams. Its technology provides a more open design and reduces fouling. Their technology offers a significant reduction in both Capital and Operating Expense in membrane plant operations.
Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science. It was founded in 1936 and headquartered in London, England.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Grant, Series C, Series B
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 126
- Round size: Grant $1.6M–$10M; Series B $18M–$68M; Series C $10M–$127M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $331M in 2018
Portfolio highlights
- Lario Therapeutics — Lario Therapeutics are developing first-in-class disease modifying treatments for severe neurological disorders. Precision Neuroscience Today.
- Wysa — Use Wysa to vent or just talk through negative thoughts and emotions. Let it help you cope with pandemic anxiety and lockdowns. It is anonymous, safe and free.
- Ineffable Intelligence — Ineffable Intelligence is an AI research company whose mission is to make first contact with superintelligence.
Santo Holding is a Zurich-based investment firm funding biotechnology, pharmaceutical, life sciences, and healthcare companies.
Show more...Investment focus
- Industry: Biotechnology, Energy, Medical
- Stage:Venture - Series Unknown, Series B, Series C
- Geography: Germany, Austria
Investor stats
- Total investments: 7
- Round size: Venture - Series Unknown $7.7M–$10M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- 4SC — 4SC discovers and develops targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases in indications with high unmet medical needs. These drugs are intended to provide innovative treatment options that are more tolerable and efficacious, and provide a better quality of life.
- AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
- Efficient Energy — Efficient Energy GmbH is an innovative manufacturer and system supplier of environmentally friendly refrigeration technology, based in Feldkirchen near Munich, Germany. The company developed the Bluezero-technology, which uses water as a refrigerant and and thereby entirely avoids fluorinated refrigerants (HFCs). Efficient Energy helps itscustomers overcome the increasing regulatory challenges of refrigeration technology, and offers them long-term, sustainable solutions with its eChiller model range. The eChiller chilled water units are ideally suited for process cooling, machine cooling and the cooling of technical equipment and data centres and provide cooling capacities from 35 kW to 120 kW, depending on the model. With its outstanding cost efficiency and low CO2 footprint, companies benefit on many fronts. The pioneering technology has also been noticed by politics and the media, and has received multiple awards for the eChiller. These include among others the European Business Award for the Environment 2018/2019 from the European Comission and the Red Herring Europe Top 100 in 2020.
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 96
- Round size: Seed $2M–$6.3M; Pre-Seed $529k–$2.4M; Series A $5M–$21M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely actively investing — fresh fund, raised $52M in 2025
Portfolio highlights
- Biobase — Biobase is the agentic system for clinical data, connecting health systems and life science teams to turn siloed clinical data into research-ready data.
- Ladder Health — Expert speech, occupational, physical, and feeding therapy for children, right from home, with flexible virtual visits and a plan that fits real life.
- Woodway Assurance — Woodway Assurance provides EviData, an AI-driven software for automated privacy assurance on de-identified and synthetic datasets.
Biopart
Show more...Investment focus
- Industry: Medical, Analytics, Health Diagnostics
- Stage:Series A
- Geography: Austria
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that helps people understand their health by explaining their medical reports and health data to them in a personalized, easy-to-understand, and visual way.Through its consumer apps and enterprise software, Medicus is focused on bringing meaning to data, by helping patients and users understand theirhealth, and augmenting the roles of doctors, midwives, and other healthcare providers through innovative data visualization, patient communication, and remote monitoring tools.
Medical Investor funding in Austria at a glance
Stats across 96 deals from 138 investors.
Access all 138 investors in Austria Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Investors in Austria investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 138 investors investing in Austria Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!